Differential propensity for major hemorrhagic events in patients with different types of arterial disease

S Achterberg1, F L J Visseren, L J Kappelle

  • 1Department of Neurology, Utrecht Stroke Center, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, the Netherlands. s.achterberg-2@umcutrecht.nl

Insights

Patients with cerebrovascular disease (CVD) or peripheral arterial obstructive disease (PAD) face a higher risk of major bleeding events than those with coronary artery disease (CAD). This increased risk is not explained by common risk factors or genetic variations.

Area of Science:

  • Cardiovascular Medicine
  • Hemorrhagic Complications
  • Atherosclerosis Research

Background:

  • Atherosclerosis is a primary cause of coronary artery disease (CAD), cerebrovascular disease (CVD), and peripheral arterial obstructive disease (PAD).
  • Previous findings indicated a two-fold higher risk of major hemorrhagic complications in patients with CVD or PAD compared to those with CAD.

Purpose of the Study:

  • To investigate whether the elevated risk of major hemorrhagic complications in CVD/PAD patients versus CAD patients is due to baseline risk factors or genetic variants in hemostasis.
  • To identify the underlying causes for differential bleeding risks among atherosclerosis subtypes.

Main Methods:

  • A cohort of 2622 patients with non-disabling CAD, CVD, or PAD was followed for a mean of 6.6 years.
  • Major hemorrhagic complications, including intracranial, fatal, and hospitalization-requiring events, were recorded.
  • Statistical analysis included hazard ratios adjusted for baseline characteristics and genetic variants.

Main Results:

  • Major hemorrhagic complications occurred in 122 patients (0.77% annual event rate).
  • Patients with CVD or PAD exhibited a significantly higher risk of major hemorrhagic complications compared to CAD patients (HR 2.05).
  • This disparity was not explained by hypertension, diabetes, renal failure, antithrombotic use, or genetic variants.

Conclusions:

  • Patients with CVD or PAD have a substantially higher risk of major hemorrhagic events than those with CAD.
  • Known risk factors, antithrombotic therapies, and genetic hemostasis variants do not account for this observed difference.
  • Further research is essential to elucidate the reasons behind this risk differential and explore potential variations in pathogenesis.
Abstract

Related Concept Videos

Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...